(CYAN) Cyanotech - Ratings and Ratios

Cyanotech Corporation (NASDAQ:CYAN) is a microalgae-based agricultural company specializing in the cultivation and production of high-value natural products. The company leverages its proprietary cultivation and extraction technologies to produce BioAstin Hawaiian Astaxanthin, a potent antioxidant used in supplements for skin, eye, joint, and immune health, and Hawaiian Spirulina Pacifica, a nutrient-dense dietary supplement rich in antioxidants, vitamins, and minerals. Its products are sold through a diversified distribution network, including online platforms, retail stores, and direct-to-consumer channels, as well as bulk sales to manufacturers and formulators in the nutraceutical, cosmetic, and health food industries. Headquartered in Kailua-Kona, Hawaii, Cyanotech operates a 90-acre production facility, enabling large-scale microalgae cultivation. The company was founded in 1983 and has established itself as a key player in the natural products sector, with a focus on sustainability and research-driven innovation.

Cyanotech Corporation is listed on the NASDAQ under the ticker symbol CYAN. The company operates within the Personal Care Products sub-industry and is classified as a common stock. Its market capitalization is approximately $2.94 million, with a price-to-book ratio of 0.28, indicating undervaluation relative to its book value. The trailing and forward price-to-earnings ratios are currently 0.00, reflecting significant earnings challenges. The companys price-to-sales ratio of 0.11 suggests potential undervaluation relative to its revenue generation. However, the return on equity (RoE) stands at -49.02%, highlighting profitability struggles. The stocks average 20-day trading volume is low at 1,585 shares, with a last price of $0.37, aligning closely with its 20-day and 50-day simple moving averages (SMA). The 200-day SMA of $0.48 indicates recent downward price momentum, while the average true range (ATR) of 0.03 reflects low volatility.